ICON ( NASDAQ: ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...

Fiduciary Management Inc. (FMI), an independent money management firm, released its “FMI International Equity Strategy ...

ICON Public Trading Down 0.5 % NASDAQ ICLR opened at $218.22 on Friday. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 0.35. ICON Public Limited has a ...

ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the ...

BitFuFu Inc. is a global leader in Bitcoin mining and comprehensive mining services, providing customers with one-stop solutions including cloud-mining. BitFuFu received early investment from BITMAIN, ...

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts ...

Preliminary fourth quarter 2024 revenue of approximately $2.41 billion increased by 25% compared with $1.93 billion in the fourth quarter of 2023. Preliminary 2024 revenue of approximately $8.35 ...

Barclays analyst Benjamin Budish maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $96.00. The company’s shares closed last Friday at $75.88.

A monthlong stock market decline sparked by surging bond yields could be interrupted by strong 4th quarter earnings.

Delivers revenue growth at the high end of previous guidance range for the quarterReturns $220 million to shareholders in fiscal 2024 through ...